Sühendan Ekmekçioğlu
- Molecular Medicine top 5%
- Immunology top 10%
- Immunotherapy and Immune Responses 6
- Mast cells and histamine 3
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 7
-
- PI3K/AKT/mTOR signaling in cancer 2
- Melanoma and MAPK Pathways 2
- Redox biology and oxidative stress 2
-
- Nitric Oxide and Endothelin Effects 3
-
- Estrogen and related hormone effects 2
- Co-authors
- Elizabeth A. GrimmKapil MehtaJansina Y. FokE. Timothy WalchMingzhong ZhengJason RoszikJulie A. EllerhorstChandrani Chattopadhyay
- Cited by
- Molecular MedicineImmunologyOncology
- Partner nations
- United StatesAustraliaDenmark
In The Last Decade
Sühendan Ekmekçioğlu
21 papers receiving 829 citations
Peers
Comparison fields: 5 of 86
- Molecular Medicine 80
- Immunology 221
- Oncology 278
- Cancer Research 139
- Molecular Biology 403
Countries citing papers authored by Sühendan Ekmekçioğlu
This map shows the geographic impact of Sühendan Ekmekçioğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sühendan Ekmekçioğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sühendan Ekmekçioğlu more than expected).
Fields of papers citing papers by Sühendan Ekmekçioğlu
This network shows the impact of papers produced by Sühendan Ekmekçioğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sühendan Ekmekçioğlu. The network helps show where Sühendan Ekmekçioğlu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sühendan Ekmekçioğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 28 | |
| 5 | 2018 | 21 | |
| 6 | 2018 | 42 | |
| 7 | 2017 | 40 | |
| 8 | 2016 | 41 | |
| 9 | 2016 | 117 | |
| 10 | 2014 | 25 | |
| 11 | 2014 | 4 | |
| 12 | 2012 | 18 | |
| 13 | 2011 | 11 | |
| 14 | 2008 | 65 | |
| 15 | 2006 | 88 | |
| 16 | 2005 | 62 | |
| 17 | 2004 | 126 | |
| 18 | A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide. | 2002 | 43 |
| 19 | 2002 | 68 | |
| 20 | 1999 | 34 |
About Sühendan Ekmekçioğlu
Sühendan Ekmekçioğlu is a scholar working on Immunology, Oncology and Biophysics, having authored 22 papers that have together received 839 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (6 papers), Nitric Oxide and Endothelin Effects (3 papers), Mast cells and histamine (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Melanoma and MAPK Pathways (2 papers), Estrogen and related hormone effects (2 papers) and Redox biology and oxidative stress (2 papers). The work is most often cited by research in Molecular Medicine (80 citations), Immunology (221 citations) and Oncology (278 citations). Sühendan Ekmekçioğlu has collaborated with scholars based in United States, Australia and Denmark. Frequent co-authors include Elizabeth A. Grimm, Kapil Mehta, Jansina Y. Fok, E. Timothy Walch, Mingzhong Zheng, Jason Roszik, Julie A. Ellerhorst, Chandrani Chattopadhyay, Sun-Hee Kim and Patrick Hwu. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.